Musculoskeletal
Cervical Ripening
1
Pipeline Programs↗
5
Active Trials↗
3
Companies Involved↗
Cervical Ripening is an early-stage landscape with 1 program across 3 companies. The most active players are Pfizer, Ferring, HUDDA Ahmad.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical1
Phase 1
No programs
Phase 2
No programs
Phase 3
No programs
Approved
No programs
Analysis
Trial Status
31
clinical trials
Completed16 · 52%
Unknown status5 · 16%
Terminated4 · 13%
Recruiting3 · 10%
Not yet recruiting1 · 3%
Withdrawn1 · 3%
Other1 · 3%
Clinical Trials
Trial Activity
31 trials
Topical Anesthesia During Catheter Insertion for Cervical Ripening (TOLERANCE)
Recruiting·—·Phase 4·NCT07288021·200 enrolled
Pain Control for Cervical Ripening Balloon
Not yet recruiting·—·Phase 2·NCT07268118·110 enrolled
Page 1 of 3
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)